The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.

BACKGROUND: The intra-tumor stroma percentage in colon cancer (CC) patients has previously been reported by our group as a strong independent prognostic parameter. Patients with a high stroma percentage within the primary tumor have a poor prognosis. PATIENTS AND METHODS: Tissue samples from the mo...

詳細記述

書誌詳細
主要な著者: Huijbers, A, Tollenaar, R, v Pelt, G, Zeestraten, E, Dutton, S, McConkey, C, Domingo, E, Smit, V, Midgley, R, Warren, B, Johnstone, E, Kerr, D, Mesker, W
フォーマット: Journal article
言語:English
出版事項: 2013

類似資料